Sartor, O., Vogelzang, N. J., Sweeney, C., Fernandez, D. C., Almeida, F., Iagaru, A., . . . Morris, M. J. (2017). Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program. Oncologist.
Chicago-стиль цитированияSartor, Oliver, et al. "Radium‐223 Safety, Efficacy, and Concurrent Use With Abiraterone or Enzalutamide: First U.S. Experience From an Expanded Access Program." Oncologist 2017.
MLA-цитированиеSartor, Oliver, et al. "Radium‐223 Safety, Efficacy, and Concurrent Use With Abiraterone or Enzalutamide: First U.S. Experience From an Expanded Access Program." Oncologist 2017.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.